AbbVie

Yahoo Finance • 3 months ago

BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)

The Only Product of Its Kind Approved for Use in Four Aesthetic Indications: Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines, Frown Lines, Crow's Feet Lines, and Now Platysma Bands in Adults1-5 With this Approv... Full story

Yahoo Finance • 3 months ago

U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease

VYALEV™ is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's disease Adults treated with VYALEV reported superior improvement in "on" time... Full story

Yahoo Finance • 3 months ago

Dividend Investor Who 'Doubled' His Passive Income to $1,000 a Month in Six Months Reveals Portfolio: Top 8 High-Yield Stocks

Dividend Investor Who 'Doubled' His Passive Income to $1,000 a Month in Six Months Reveals Portfolio: Top 8 High-Yield Stocks Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As enthusi... Full story

Yahoo Finance • 3 months ago

Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade

The major U.S. stock market indexes are officially in overheated territory thanks to enthusiasm for artificial intelligence (AI). Since the end of 2022, the most popular benchmark, the S&P 500 index, has soared about 51% to a rich valuatio... Full story

Yahoo Finance • 3 months ago

Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal

Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal Blue Shield of California is shaking up the pharmacy landscape with a landmark deal to drastically reduce the price of a biosimilar alternative to AbbVie Inc.’s (... Full story

Yahoo Finance • 3 months ago

AbbVie Inc. (ABBV) Projects Mid-Single-Digit Sales Growth Over Next 3 Years

We recently published a list of 8 Best Inexpensive Stocks To Invest In Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other best inexpensive stocks to invest in now. Are Experts Alrea... Full story

Yahoo Finance • 3 months ago

15 Best Dividend Stocks for Lifelong Passive Income

Dividend stocks offer a path to steady passive income, but not all are created equal. The key to long-term success lies in dividend sustainability, not just high current yields. The payout ratio serves as a critical tool for assessing sus... Full story

Yahoo Finance • 3 months ago

Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential

Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential On Thursday, the FDA approved Bristol Myers Squibb & Co’s (NYSE:BMY) Cobenfy (xanomeline and trospium chloride, KarXT),... Full story

Yahoo Finance • 3 months ago

AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer

- Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression. - Biologics License Application (BLA) submission for acc... Full story

Yahoo Finance • 4 months ago

Bausch + Lomb explores sale amid parent company's debt woes - report

Investing.com -- Bausch + Lomb (NYSE:BLCO) is exploring a potential sale as part of an effort to resolve issues related to its separation from parent company Bausch Health, which is burdened with significant debt, as per a Financial Times... Full story

Yahoo Finance • 4 months ago

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

In one sense, there's no such thing as easy money. However, once you have money accumulated to invest, it can be easy to make more. That's the key to generating passive income. Some investment options require constant monitoring. You migh... Full story

Yahoo Finance • 4 months ago

Health Canada Approves AbbVie's CONSTELLA® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients 6 to 17 Years of Age

CONSTELLA is the first and only Health Canada-approved prescription therapy for functional constipation in this patient population Submission is based on positive Phase 3 study data demonstrating linaclotide (72mcg) resulted in increases i... Full story

Yahoo Finance • 4 months ago

AbbVie Declares Quarterly Dividend

NORTH CHICAGO, Ill., Sept. 6, 2024 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.55 per share. The cash dividend is payable November 15, 2024, to stockholders of record a... Full story

Yahoo Finance • 4 months ago

AbbVie Inc (ABBV): A Good 52-Week High Stock to Buy According to Short Sellers

We recently compiled a list of the 14 Best 52-Week High Stocks to Buy According to Short Sellers.In this article, we are going to take a look at where AbbVie Inc (NYSE:ABBV) stands against the other 52-week high stocks. The U.S. stock mar... Full story

Yahoo Finance • 4 months ago

2 Dividend Stocks You Can Safely Hold Through a Recession

Recessions are difficult to predict. Even professional economists sometimes get it wrong. But they will happen occasionally and sometimes take the stock market down. That's why it's useful for investors to buy shares of companies that can... Full story

Yahoo Finance • 4 months ago

2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer

Did you know that September is generally a lousy month for the stock market? Individual investors and hedge fund managers tend to take profits they've gained over the summer or sell off any losers to lower their taxable income. This Septe... Full story

Yahoo Finance • 4 months ago

Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory

We came across a bullish thesis on Aldeyra Therapeutics Inc (ALDX) on ValueInvestorsClub by MrStingy. In this article we will summarize the bulls' thesis on ALDX. Aldeyra Therapeutics shares were trading at $4.15 when this thesis was publi... Full story

Yahoo Finance • 4 months ago

2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher

Many investors are worried about a resurgence of turbulence in the markets and what that could mean for stocks in the weeks and months ahead. But great businesses can withstand the test of time and provide meaningful portfolio returns. Con... Full story

Yahoo Finance • 4 months ago

3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever

Almost every portfolio needs a couple of anchor stocks that tend to grow consistently over time regardless of the mood of the market or the state of the economy. Thanks to the must-buy nature of lifesaving medicines and the regular launch... Full story

Yahoo Finance • 4 months ago

As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors

As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors Wednesday, Neurocrine Biosciences, Inc. (NASDAQ:NBIX) topline data for its Phase 2 clinical study of NBI-1117568... Full story